Oncology PracticeHow AI Is Revolutionizing Drug Repurposing for Faster, Broader ImpactOctober 8, 2024Business of MedicinePharmacyPractice Management
Hematology TimesFDA’s Project Optimus aims to transform early cancer researchNovember 14, 2023PharmacyALLAMLCMLDLBCLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Oncology PracticeOral cancer drugs requiring prior authorization on the riseJuly 27, 2023PharmacyMixed Topics
Hematology TimesFDA approves dasatinib for kids with Ph+ ALLJanuary 3, 2019Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Hematology TimesEC approves split dosing regimen for daratumumabJanuary 3, 2019Multiple MyelomaPharmacy
Hematology TimesFDA approves first treatment for BPDCNDecember 26, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesFDA approves ravulizumab for PNHDecember 25, 2018AnemiaThrombosisPharmacyBleeding Disorders
Hematology TimesFDA approves calaspargase pegol-mknl for ALLDecember 24, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Hematology TimesCHMP recommends treosulfan for allo-HSCT conditioningDecember 21, 2018PharmacyTransplantation
Hematology TimesCHMP backs lusutrombopag for severe thrombocytopeniaDecember 21, 2018AnemiaBlood BankingPharmacy
Hematology TimesCHMP backs dasatinib for kids with newly diagnosed ALLDecember 19, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Hematology TimesHealth Canada approves new indication for daratumumabDecember 18, 2018Multiple MyelomaPharmacy
Hematology TimesCHMP recommends BV+AVD for Hodgkin lymphomaDecember 18, 2018Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesRomiplostim now approved for children with ITPDecember 15, 2018AnemiaPediatricsPharmacyBleeding Disorders
